Advanced company searchLink opens in new window

BEAD BIOPHARMA LIMITED

Company number SC763273

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
19 Apr 2024 AP01 Appointment of Dr Daniel Ozanne as a director on 19 April 2024
08 Apr 2024 SH02 Sub-division of shares on 2 April 2024
03 Apr 2024 MA Memorandum and Articles of Association
03 Apr 2024 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
  • RES13 ‐ Subdivision of shares: 2000 £0.01 ordinary shares divided into 200000 £0.0001 ordinary shares 02/04/2024
  • RES01 ‐ Resolution of adoption of Articles of Association
02 Apr 2024 AP01 Appointment of Mr Michael Sun as a director on 2 April 2024
02 Apr 2024 SH01 Statement of capital following an allotment of shares on 2 April 2024
  • GBP 28.5715
25 Mar 2024 CS01 Confirmation statement made on 21 March 2024 with no updates
15 Dec 2023 AD01 Registered office address changed from 16 Seymour Avenue Dundee DD2 1HG Scotland to 6 Logie Mill Edinburgh EH7 4HG on 15 December 2023
03 Nov 2023 AD01 Registered office address changed from Brook House 86 Brook Street Broughty Ferry Dundee DD5 1DQ Scotland to 16 Seymour Avenue Dundee DD2 1HG on 3 November 2023
17 Jul 2023 TM01 Termination of appointment of Alan Michael Raymond as a director on 11 July 2023
22 Mar 2023 NEWINC Incorporation
Statement of capital on 2023-03-22
  • GBP 20
  • MODEL ARTICLES ‐ Model articles adopted